New developments in the treatment of partial-onset epilepsy

References

• KwanPBrodieMJEffectiveness of first antiepileptic drugEpilepsia2001421255126011737159
   PubMed Web of Science ®Google Scholar
• BrodieMJKwanPStaged approach to epilepsy managementNeurology200258S2S811971127
   PubMed Web of Science ®Google Scholar
• AldenkampAPAlphertsWCThe effect of the new antiepileptic drug rufinamide on cognitive functionsEpilepsia2006471153115916886978
   PubMed Web of Science ®Google Scholar
• BesagFMBehavioural effects of the new anticonvulsantsDrug Saf20012451353611444724
   PubMed Web of Science ®Google Scholar
• JacobyASnapeDBakerGADeterminants of quality of life in people with epilepsyNeurol Clin20092784386319853212
   PubMed Web of Science ®Google Scholar
• CramerJABrandenburgNAXuXVera-LlonchMOsterGThe impact of seizures and adverse effects on global health ratingsEpilepsy Behav20071117918417681863
   PubMed Web of Science ®Google Scholar
• EkeTTalbotJFLawdenMCSevere persistent visual field constriction associated with vigabatrinBMJ19973141801819022432
   PubMed Web of Science ®Google Scholar
• Felbamate linked to aplastic anemia; warning issued on drug’s useAm J Hosp Pharm1994511923247847395
   PubMedGoogle Scholar
• PellockJMFelbamate in epilepsy therapy: evaluating the risksDrug Saf19992122523910487399
   PubMed Web of Science ®Google Scholar
• BesagFMDoddSWhen can a drug be declared “safe”Curr Drug Saf2010511211320392200
   PubMedGoogle Scholar
• ChadwickDSmithDThe misdiagnosis of epilepsyBMJ200232449549611872532
   PubMed Web of Science ®Google Scholar
• UldallPAlvingJHansenLKKibaekMBuchholtJThe misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal eventsArch Dis Child20069121922116492886
   PubMed Web of Science ®Google Scholar
• McIntoshAMWilsonSJBerkovicSFSeizure outcome after temporal lobectomy: current research practice and findingsEpilepsia2001421288130711737164
   PubMed Web of Science ®Google Scholar
• WiebeSBlumeWTGirvinJPEliasziwMEffectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study GroupA randomized, controlled trial of surgery for temporal-lobe epilepsyNew Engl J Med2001345531131811484687
   PubMed Web of Science ®Google Scholar
• ColonnelliMCCrossJHDaviesSPsychopathology in children before and after surgery for extratemporal lobe epilepsyDev Med Child Neurol20125452152622500653
   PubMed Web of Science ®Google Scholar
• GlosserGZwilASGlosserDSO’ConnorMJSperlingMRPsychiatric aspects of temporal lobe epilepsy before and after anterior temporal lobectomyJ Neurol Neurosurg Psychiatry200068535810601402
   PubMed Web of Science ®Google Scholar
• BlumerDWakhluSDaviesKHermannBPsychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complicationsEpilepsia1998394784869596199
   PubMed Web of Science ®Google Scholar
• MarangellLBRushAJGeorgeMSVagus nerve stimulation (VNS) for major depressive episodes: one year outcomesBiol Psychiatry20025128028711958778
   PubMed Web of Science ®Google Scholar
• KlinkenbergSMajoieHJvan der HeijdenMMRijkersKLeenenLAldenkampAPVagus nerve stimulation has a positive effect on mood in patients with refractory epilepsyClin Neurol Neurosurg201211433634022130047
   PubMed Web of Science ®Google Scholar
• LockmanJFisherRSTherapeutic brain stimulation for epilepsyNeurol Clin2009271031104019853222
   PubMed Web of Science ®Google Scholar
• SchefferIEBerkovicSFThe genetics of human epilepsyTrends Pharmacol Sci20032442843312915053
   PubMed Web of Science ®Google Scholar
• BesagFMCAdvances in epilepsyCurr Opin Psychiatry199912549553
   Web of Science ®Google Scholar
• BerkovicSFMulleyJCThe first gene for an idiopathic epilepsy: a fruitful collaboration of Australian clinical research and molecular genetics [editorial]Aust N Z J Med1996261541568744611
   PubMedGoogle Scholar
• DibbensLMTarpeyPSHynesKX-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentNat Genet20084077678118469813
   PubMed Web of Science ®Google Scholar
• GuerriniRDravetCGentonPBelmonteAKaminskaADulacOLamotrigine and seizure aggravation in severe myoclonic epilepsyEpilepsia1998395085129596203
   PubMed Web of Science ®Google Scholar
• ChironCDulacOBeaumontDPalaciosLPajotNMumfordJTherapeutic trial of vigabatrin in refractory infantile spasmsJ Child Neurol1991Suppl 2S52S591940125
   PubMed Web of Science ®Google Scholar
• LowensteinDHEpilepsy after head injury: an overviewEpilepsia200950Suppl 24919187288
   PubMed Web of Science ®Google Scholar
• DuncanJSImaging and epilepsyBrain19971203393779117380
   PubMed Web of Science ®Google Scholar
• VincentABienCGIraniSRWatersPAutoantibodies associated with diseases of the CNS: new developments and future challengesLancet Neurol20111075977221777830
   PubMed Web of Science ®Google Scholar
• GlauserTBen-MenachemEBourgeoisBILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia2006471094112016886973
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceThe epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary careNICE clinical guideline137 Issued: Jan 2012. Available from: http://guidance.nice.org.uk/CG137Accessed August 19, 2012
   Google Scholar
• AldenkampAPAlphertsWCJDiepmanLVan’t SlotBOverwegJVermeulenJCognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsyEpilepsy Res19941937437813412
   PubMed Web of Science ®Google Scholar
• WerlinSLFishDLThe spectrum of valproic acid-associated pancreatitisPediatrics20061181660166317015559
   PubMed Web of Science ®Google Scholar
• MorrowJRussellAGuthrieEMalformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJ Neurol Neurosurg Psychiatry20067719319816157661
   PubMed Web of Science ®Google Scholar
• AdabNKiniUVintenJThe longer term outcome of children born to mothers with epilepsyJ Neurol Neurosurg Psychiatry2004751575158315491979
   PubMed Web of Science ®Google Scholar
• MeadorKJBakerGABrowningNCognitive function at 3 years of age after fetal exposure to antiepileptic drugsN Engl J Med20093601597160519369666
   PubMed Web of Science ®Google Scholar
• LeppikIEZonisamide: chemistry, mechanism of action, and pharmacokineticsSeizure200413Suppl 1S5S915511691
   PubMed Web of Science ®Google Scholar
• WhiteJRWalczakTSMarinoSEBeniakTELeppikIEBirnbaumAKZonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control studyNeurology20107551351820697103
   PubMed Web of Science ®Google Scholar
• MeldrumBSUpdate on the mechanism of action of antiepileptic drugsEpilepsia199637Suppl 6S4S118941036
   PubMed Web of Science ®Google Scholar
• CoulterDAAntiepileptic drug cellular mechanisms of action: where does lamotrigine fit in?J Child Neurol199712Suppl 1S2S99429123
   PubMed Web of Science ®Google Scholar
• ZhengCYangKLiuQThe anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptorsJ Pharmacol Exp Ther201033540140820688974
   PubMed Web of Science ®Google Scholar
• MarsonAGAl-KharusiAMAlwaidhMThe SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialLancet20073691000101517382827
   PubMed Web of Science ®Google Scholar
• GubermanAHBesagFMBrodieMJLamotrigine-associated rash: risk/benefit considerations in adults and childrenEpilepsia19994098599110403224
   PubMed Web of Science ®Google Scholar
• SabersABuchholtJMUldallPHansenELLamotrigine plasma levels reduced by oral contraceptivesEpilepsy Res20014715115411673029
   PubMed Web of Science ®Google Scholar
• SchmutzMBruggerFGentschCMcLeanMJOlpeHROxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of actionEpilepsia199435Suppl 5S47S508039471
   PubMed Web of Science ®Google Scholar
• JohannessenACNielsenOAHyponatremia induced by oxcarbazepineEpilepsy Res198711551563143548
   PubMed Web of Science ®Google Scholar
• RhoJMDonevanSDRogawskiMAMechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptorsAnn Neurol1994352292348109904
   PubMed Web of Science ®Google Scholar
• GeeNSBrownJPDissanayakeVUOffordJThurlowRWoodruffGNThe novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channelJ Biol Chem1996271576857768621444
   PubMed Web of Science ®Google Scholar
• PeruccaEBialerMThe clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabineClin Pharmacokinet19963129468827398
   PubMed Web of Science ®Google Scholar
• AldenkampAPBakerGMulderOGA multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizuresEpilepsia2000411167117810999556
   PubMed Web of Science ®Google Scholar
• VoglCMochidaSWolffCWhalleyBJStephensGJThe The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathwayMol Pharmacol20128219920822554805
   PubMed Web of Science ®Google Scholar
• LiZTaylorCPWeberMPregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunitsEur J Pharmacol2011667809021651903
   PubMed Web of Science ®Google Scholar
• ArroyoSRufinamideNeurotherapeutics2007415516217199032
   PubMed Web of Science ®Google Scholar
• ElgerCEStefanHMannANarurkarMSunYPerdomoCA 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizuresEpilepsy Res20108825526320061123
   PubMed Web of Science ®Google Scholar
• PoissonMHuguetFSavattierABakri-LogeaisFNarcisseGA new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical studyArzneimittelforschung1984341992046326778
   PubMed Web of Science ®Google Scholar
• GiraudCTreluyerJMReyEIn vitro and in vivo inhibitory effect of stiripentol on clobazam metabolismDrug Metab Dispos20063460861116415114
   PubMed Web of Science ®Google Scholar
• FattoreCPeruccaENovel medications for epilepsyDrugs2011712151217822035515
   PubMed Web of Science ®Google Scholar
• PatsalosPNBerryDJPharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetateExpert Opin Pharmacother20121369971522404663
   PubMed Web of Science ®Google Scholar
• ElgerCHalaszPMaiaJAlmeidaLSoares-da-SilvaPInvestigators Study GroupEfficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III studyEpilepsia20095045446319243424
   PubMed Web of Science ®Google Scholar
• Gil-NagelALopes-LimaJAlmeidaLMaiaJSoares-da-SilvaPInvestigators Study GroupEfficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizuresActa Neurol Scand200912028128719832771
   PubMed Web of Science ®Google Scholar
• Ben-MenachemEGabbaiAAHufnagelAMaiaJAlmeidaLSoares-da-SilvaPEslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsyEpilepsy Res20108927828520299189
   PubMed Web of Science ®Google Scholar
• ErringtonACStohrTHeersCLeesGThe investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channelsMol Pharmacol20087315716917940193
   PubMed Web of Science ®Google Scholar
• ChungSSperlingMRBitonVLacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trialEpilepsia20105195896720132285
   PubMed Web of Science ®Google Scholar
• ChungSBen-MenachemESperlingMRExamining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trialsCNS Drugs2010241041105421090838
   PubMed Web of Science ®Google Scholar
• MainMJCryanJEDupereJRCoxBClareJJBurbidgeSAModulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabineMol Pharmacol20005825326210908292
   PubMed Web of Science ®Google Scholar
• WuttkeTVSeebohmGBailSMaljevicSLercheHThe new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gateMol Pharmacol2005671009101715662042
   PubMed Web of Science ®Google Scholar
• LangeWGeissendorferJSchenzerARefinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channelsMol Pharmacol20097527228019015229
   PubMed Web of Science ®Google Scholar
• PorterRJPartiotASachdeoRNohriaVAlvesWMStudy GroupRandomized, multicenter, dose-ranging trial of retigabine for partialonset seizuresNeurology2007681197120417420403
   PubMed Web of Science ®Google Scholar
• BrodieMJLercheHGil-NagelAEfficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsyNeurology2010751817182420944074
   PubMed Web of Science ®Google Scholar
• FrenchJAAbou-KhalilBWLeroyRFRandomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsyNeurology2011761555156321451152
   PubMed Web of Science ®Google Scholar
• RogawskiMARevisiting AMPA receptors as an antiepileptic drug targetEpilepsy Curr201111566321686307
   PubMed Web of Science ®Google Scholar
• SveinbjornsdottirSSanderJWUptonDThe excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsyEpilepsy Res1993161651748269915
   PubMed Web of Science ®Google Scholar
• PitkanenAMathiesenCRonnLCMollerANissinenJEffect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in ratEpilepsy Res200774455417289347
   PubMed Web of Science ®Google Scholar
• FritschBStottJJJoelleDJRogawskiMATreatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466Epilepsia20105110811719682025
   PubMed Web of Science ®Google Scholar
• RogawskiMALow affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents – toward an understanding of their favorable tolerabilityAmino Acids20001913314911026482
   PubMed Web of Science ®Google Scholar
• LanganYMLucasRJewellHTalampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsyEpilepsia200344465312581229
   PubMed Web of Science ®Google Scholar
• HanadaTHashizumeYTokuharaNPerampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsyEpilepsia2011521331134021635236
   PubMed Web of Science ®Google Scholar
• KraussGLBarMBitonVTolerability and safety of perampanel: two randomized dose-escalation studiesActa Neurol Scand201212581521883097
   PubMed Web of Science ®Google Scholar
• FrenchJElgerCGoldberg-SternHUse of perampanel, a selective, non-competitive AMPA receptor antagonist, as adjunctive therapy in patients with refractory partial onset seizures: results of a global phase III studyEpilepsia20115210
   Web of Science ®Google Scholar
• KraussGLSerratosaJMVillanuevaVRandomised phase III study 306: adjunctive perampanel for refractory partial-onset seizuresNeurology2012781408141522517103
   PubMed Web of Science ®Google Scholar